Source: International Congress 2016 – Prognostic variables in lung cancer II
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Cagatay Tezel (Istanbul, Turkey), Cagatay Tezel, Mustafa Akyil, Serdar Evman, Serda Kanbur, Talha Dogruyol, Levent Alpay, Cansel Atinkaya Ozturk, Volkan Baysungur, Irfan Yalcinkaya. Diaphragm invasion worsen the prognosis as indicated in the 8th TNM. Eur Respir J 2016; 48: Suppl. 60, 2872

Member's Comments

No comment yet.

Related content which might interest you: Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis? Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Segmentectomy for second lung cancer after lobectomy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Does the type of N1 state different survival Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Futile thoracotomy in lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Revision of descriptors in forthcoming VIII edition of TNM classification of lung cancer: A single center validation study Source: International Congress 2016 – Current challenges in thoracic surgery Year: 2016 Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Reduced perioperative mortality after centralization of lung cancer surgery Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit? Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 The prognostic value of D-dimer in lung carcinoma Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Extended anatomical VATS resections in patients with NSCLC Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Robot-assisted operations in the diagnosis and treatment of intrathoracic tumors Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015